drugset / Trial / NCT01804673

A Study to Evaluate the Safety and Tolerability of Fentanyl Iontophoretic Transdermal System (Fentanyl-ITS) in the Management of Post-Surgery Pain

NCT01804673 ↗

Phase 4 Terminated 174 enrolled Janssen-Cilag GmbH
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety and tolerability of the fentanyl iontophoretic transdermal (through the skin) system (fentanyl-ITS) in daily clinical practice for management of acute (a quick and severe form of illness in its early stage) moderate to severe post-operative pain (pain after surgery) including the comprehensibility and usefulness of the accompanying information material.

Timeline

Start
2008-03
Primary completion
2008-09
Completion
2008-09

Outcome

Outcome not reported

Stopped: “The study was prematurely discontinued since study medication was no longer available.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 40 ug Other

Indications

No indication recorded.